Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction

doi:10.4240/wjgs.v14.i8.788

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4870)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

163

WORD

HTML

1541

Figures (1-7)

271

Tables (1-4)

256

Sum=2291

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

252

Download

743

Sum=995

Publishing Process of This Article

Item

Count

Browse

405

Download

1179

Sum=1584

Aug 27, 2022 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Aug 27, 2022; 14(8): 788-798
Published online Aug 27, 2022. doi: 10.4240/wjgs.v14.i8.788

Full Size Figure Download Figure

Figure 2 Calibration curves of the prognostic nomogram for 3-year overall survival. TNM: Tumor-node-metastasis; BMI: Body mass index; NLR: Neutrophil-to-lymphocyte ratio.

Citation: Wei ZJ, Qiao YT, Zhou BC, Rankine AN, Zhang LX, Su YZ, Xu AM, Han WX, Luo PQ. Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction. World J Gastrointest Surg 2022; 14(8): 788-798
URL: https://www.wjgnet.com/1948-9366/full/v14/i8/788.htm
DOI: https://dx.doi.org/10.4240/wjgs.v14.i8.788